ADVFN - Advanced Financial Network.
HOME» NYSE » G » GSK Stock Price » GSK Stock News

Glaxosmithkline Share News

 Glaxosmithkline Stock Price
GSK Stock Price
 Glaxosmithkline Stock Chart
GSK Stock Chart
 Glaxosmithkline Stock News
GSK Stock News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Stock Trades
GSK Stock Trades

GlaxoSmithKline Buys Back 450,000 Shares

LONDON--GlaxoSmithKline PLC (GSK.LN) Wednesday said it purchased 450,000 ordinary shares on Aug. 8. MAIN FACTS: -Highest price paid per share was 1507 pence per share. -Lowest price paid per share was 1488 pence per share. -Intends to hold the shares in treasury. -Shares on Wednesday closed at 1507 pence. -Write to Tapan Panchal at Subscribe to WSJ:

Stock News for Glaxosmithkline (GSK)
10/24/201602:50:00GlaxoSmithKline Seeks US Regulatory Approval for Shingles Vaccine
10/21/201613:06:39Report of Foreign Issuer (6-k)
10/18/201608:15:11Report of Foreign Issuer (6-k)
10/18/201608:08:13Report of Foreign Issuer (6-k)
10/18/201607:57:28Report of Foreign Issuer (6-k)
10/18/201607:37:45Report of Foreign Issuer (6-k)
10/17/201616:26:49Report of Foreign Issuer (6-k)
10/17/201615:59:28Report of Foreign Issuer (6-k)
10/17/201614:03:14Report of Foreign Issuer (6-k)
10/14/201614:12:15Report of Foreign Issuer (6-k)
10/14/201614:09:44Report of Foreign Issuer (6-k)
10/14/201614:05:53Report of Foreign Issuer (6-k)
10/12/201613:50:00Report of Foreign Issuer (6-k)
10/11/201607:12:40Report of Foreign Issuer (6-k)
10/04/201606:01:50Notice of Effectiveness (effect)
10/03/201609:23:10Report of Foreign Issuer (6-k)
10/02/201623:40:00Novo Nordisk Bets on Riskier Insulin Research
09/30/201617:20:00GlaxoSmithKline to Pay $20 Million to Settle SEC Bribery Probe
09/30/201617:15:00GlaxoSmithKline to Pay $20 Million to Settle SEC Bribery Probe
09/29/201618:20:00ADRs End Lower; Novo Nordisk Falls

Glaxosmithkline and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations